<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Peerawat Jinatongthai และ Wannisa Dongtai; Boonthida Aonsuebsai; Possawat Towongsricharoen; Thanatcha Songmuang; Sawaeng Watcharathanakij; Surakit Nathisuwan. (2021) VALIDATION OF THE POOLED COHORT RISK SCORE AND THE THAI CV RISK SCORE FOR ATHEROSCLEROSIS-CARDIOVASCULAR DISEASE (ASCVD) RISK PREDICTION AT WARINCHAMRAB HOSPITAL. &lt;i&gt;Thai Bulletin of Pharmaceutical Sciences&lt;/i&gt;, &lt;i&gt;16&lt;/i&gt;(2(July-December)2021), 71-81.</APA><Chicago>Peerawat Jinatongthai และ Wannisa Dongtai; Boonthida Aonsuebsai; Possawat Towongsricharoen; Thanatcha Songmuang; Sawaeng Watcharathanakij; Surakit Nathisuwan. "VALIDATION OF THE POOLED COHORT RISK SCORE AND THE THAI CV RISK SCORE FOR ATHEROSCLEROSIS-CARDIOVASCULAR DISEASE (ASCVD) RISK PREDICTION AT WARINCHAMRAB HOSPITAL". Thai Bulletin of Pharmaceutical Sciences  16 (2021):71-81.</Chicago><MLA>Peerawat Jinatongthai และ Wannisa Dongtai; Boonthida Aonsuebsai; Possawat Towongsricharoen; Thanatcha Songmuang; Sawaeng Watcharathanakij; Surakit Nathisuwan. VALIDATION OF THE POOLED COHORT RISK SCORE AND THE THAI CV RISK SCORE FOR ATHEROSCLEROSIS-CARDIOVASCULAR DISEASE (ASCVD) RISK PREDICTION AT WARINCHAMRAB HOSPITAL. Faculty of pharmacy, Silpakorn University:ม.ป.ท. 2021.</MLA></bibliography></xml>
